Feb 28, 2017 12:01 pm UTC| Business
BERKELEY, Calif., Feb. 28, 2017 -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Jim Neal, Chief Executive Officer, will present the company’s...
Feb 28, 2017 12:01 pm UTC| Business
BERKELEY, Calif., Feb. 28, 2017 -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Jim Neal, Chief Executive Officer, will present the company’s...
Feb 28, 2017 12:01 pm UTC| Business
Allowed patent application claims methods for generating radioimmunoconjugates linked to Actinium-225Patent expected to expire in July 2030 NEW YORK, Feb. 28, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM)...
Feb 28, 2017 12:01 pm UTC| Business
Allowed patent application claims methods for generating radioimmunoconjugates linked to Actinium-225Patent expected to expire in July 2030 NEW YORK, Feb. 28, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM)...
Feb 28, 2017 12:01 pm UTC| Business
NEW HAMPTON, N.Y., Feb. 28, 2017 -- Balchem Corporation (NASDAQ:BCPC) today reported for the fourth quarter 2016 net earnings of $15.9 million, compared to net earnings of $15.7 million for the fourth quarter 2015....
Feb 28, 2017 12:01 pm UTC| Business
NEW HAMPTON, N.Y., Feb. 28, 2017 -- Balchem Corporation (NASDAQ:BCPC) today reported for the fourth quarter 2016 net earnings of $15.9 million, compared to net earnings of $15.7 million for the fourth quarter 2015....
Antares Pharma to Present at the Cowen and Company 37th Annual Healthcare Conference
Feb 28, 2017 12:01 pm UTC| Business
EWING, N.J., Feb. 28, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 37th Annual Healthcare Conference on...